Johnson & Johnson
JNJNYSEHealthcare● Active
$233.28
+$0.51(+0.22%)
Market Cap$561.6B
P/E Ratio—
52W High$251.71
52W Low$149.04
Johnson & Johnson (JNJ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · JNJ · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2023-01 | 2022-01 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $78.74B |
| Cost of Revenue | $25.64B | $27.47B | $26.55B | $24.60B | $23.40B |
| Gross Profit | $68.56B | $61.35B | $58.61B | $55.39B | $55.34B |
| Gross Margin %(computed) | 72.78% | 69.07% | 68.82% | 69.25% | 70.28% |
| Operating Expenses | |||||
| R&D Expenses | $14.66B | $17.23B | $15.09B | $14.13B | $14.28B |
| G&A Expenses | $23.68B | $21.97B | $20.11B | $20.25B | $20.12B |
| Total Operating Expenses | $42.96B | $39.20B | $35.20B | $34.38B | $34.40B |
| Operating Income | $25.60B | $22.15B | $23.41B | $21.01B | $20.94B |
| Operating Margin %(computed) | 27.17% | 24.94% | 27.49% | 26.27% | 26.60% |
| Interest Income | $1.06B | $1.33B | $1.26B | $0.49B | $0.05B |
| Interest Expense | $0.97B | $0.76B | $0.77B | $0.28B | $0.18B |
| Income Before Tax | $32.58B | $16.69B | $15.06B | $19.36B | $19.18B |
| Income Tax Expense | $5.78B | $2.62B | $1.74B | $2.99B | $1.38B |
| Net Income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B |
| Net Margin %(computed) | 28.46% | 15.84% | 41.28% | 22.43% | 26.52% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $11.03 | $5.84 | $13.88 | $6.83 | $7.93 |
| Wtd Avg Shares | 2.43B | 2.41B | 2.53B | 2.61B | 2.63B |
| EBITDA | $41.05B | $24.78B | $23.32B | $26.61B | $26.75B |
| EBITDA Margin %(computed) | 43.59% | 27.90% | 27.38% | 33.26% | 33.97% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Johnson & Johnson data
About Johnson & Johnson (JNJ) Income Statement
Johnson & Johnson (JNJ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, JNJ reported revenue of $94.19B, gross profit of $68.56B (gross margin 72.78%), and net income of $26.80B — a net profit margin of 28.46%.
Frequently asked questions
JNJ · 4 questionsJohnson & Johnson (JNJ) reported revenue of $94.19B for 2025, up 6.0% year-over-year.
JNJ revenueJNJ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08